These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7358769)

  • 1. Overadditive chemotherapeutic synergism of prospidine and inosine when given sequentially to the Sarcoma 180 implanted intramuscularly.
    Osswald H; Youssef M
    J Cancer Res Clin Oncol; 1980 Jan; 96(1):115-9. PubMed ID: 7358769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the chemotherapeutic action of bleomycin by combination with inosine on HRS-sarcoma.
    Osswald H; Youssef M
    Cancer Lett; 1975 Sep; 1(1):55-8. PubMed ID: 65212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of 11-deoxycortiocosterone acetate on the antitumor activity of prospidin].
    Kravchenko AI; Chernov VA
    Vopr Onkol; 1975; 21(12):33-7. PubMed ID: 1210128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prospidine administered at different times of the day on the development and growth of N-nitrosomethylurea-induced mammary tumors in Wistar rats.
    Pérez-López FR; Urcia M; Torralba R; Lafarga L; Hergueta J
    Cancer Lett; 1984 Aug; 24(1):111-8. PubMed ID: 6498795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined chemotherapy of disseminated skin melanoma].
    Dement'eva NP; Voznyĭ EK; Koroleva LA
    Vopr Onkol; 1978; 24(11):48-53. PubMed ID: 741699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anticancer drug prospidine: failure to reveal antimitotic and clastogenic action on regenerating mouse liver.
    Uryvaeva IV; Sokolova AS; Faktor VM; Chernov VA; Brodsky WYa
    Neoplasma; 1983; 30(4):457-62. PubMed ID: 6888609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between means of administration, concentration in the blood, organ distribution and excretion of prespidin-14C from the body].
    Bogomolova NS; Suskova VS; Chernov VA; Serebriakov NG
    Farmakol Toksikol; 1976; 39(6):742-6. PubMed ID: 1024845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new basic agent prospidin in the therapy of rheumatoid arthritis. An evaluation of the clinical effectiveness and the mechanism of action of prospidin].
    Benenson EV; Nemtsov BF; Krasnov SL
    Ter Arkh; 1986; 58(12):103-8. PubMed ID: 3547750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prospidine on survival and growth of mammalian cells in culture.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    J Natl Cancer Inst; 1980 Nov; 65(5):993-9. PubMed ID: 6933266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprinosine increases the antitumor action of interferon.
    Cerutti I; Chany C; Schlumberger JF
    Cancer Treat Rep; 1978 Nov; 62(11):1971-4. PubMed ID: 83190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thermodynamic and spectral study of DNA-prospidin complex].
    Fedorov VF; Zozulia VN; Piatigorskaia TL; Chernov VA; Blagoĭ IuP
    Mol Biol (Mosk); 1989; 23(5):1440-6. PubMed ID: 2608045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with intratumoral prospidium chloride of cancer of the mammae induced by N-nitrosomethylurea in the rat].
    Urcia M; Leal MC; Lafarga L; Guillén V; Hergueta J; Pérez-López FR
    Rev Esp Oncol; 1984; 31(4):601-4. PubMed ID: 6571330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Visceral lesions in Kaposi angioreticulosis and effect of prospidine therapy].
    Shaposhnikova OK; Rodionov AN
    Vestn Dermatol Venerol; 1977 Jul; (7):49-52. PubMed ID: 899237
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-pharmacological study of prospidin].
    Perevodchikova NI; Lichinitser MR; Akyshbaev AA; Averinova SG; Bassalyk LS
    Vopr Onkol; 1983; 29(2):51-6. PubMed ID: 6188275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The testing of the carcinogenicity of dispirotripiperazine derivatives by combined administration with sodium nitrite].
    Lavrik OI; Kinzirskiĭ AS; Shashkina LF; Ivanova VM; Kruglova ON
    Eksp Klin Farmakol; 1993; 56(3):54-7. PubMed ID: 8219995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of prospidin in the combination chemotherapy of recurrences of generalized forms of lymphogranulomatosis].
    Vinokurova NA; Danova LA; Kondrat'ev VB; Gershanovich ML
    Vopr Onkol; 1983; 29(7):46-50. PubMed ID: 6880132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-morphological characteristics of mycosis fungoides during the treatment with prospidin in combination with corticosteroid hormones].
    Tevzadze MSh
    Vestn Dermatol Venerol; 1982 Apr; (4):10-4. PubMed ID: 7090532
    [No Abstract]   [Full Text] [Related]  

  • 19. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of radiation and chemoradiation therapy in esophageal cancer].
    Azhigaliev NA; Kusherbaev SK; Sadykov SS; Asanov AA; Fel'dman SZ
    Med Radiol (Mosk); 1990 Jun; 35(6):20-3. PubMed ID: 1694002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.